Introduction {#S0001}
============

Gastric cancer (GC) is one of the most common cancer worldwide.[@CIT0001],[@CIT0002] There are 498,000 new cases and 679,100 deaths from GC annually.[@CIT0003] However, the true mechanism of gastric cancer is still unclear. *Helicobacter pylori* (HP) infection is undoubtedly an important risk factor for gastric cancer.[@CIT0004] However, studies indicated that only a small percentage of infected patients would finally develop into GC.[@CIT0005],[@CIT0006] In this regard, several reports indicated that tumor angiogenesis of GC is controlled by numerous factors, including the regulation of many long non-coding RNAs (lncRNAs).[@CIT0007]--[@CIT0011] Recently, lncRNAs and their variants has been widely explored for its role in the development and prognosis of many tumors, including pancreatic cancer, GC, non-small cell lung cancer, breast cancer, tongue squamous cell carcinoma, and so on.[@CIT0012]--[@CIT0021] For GC, genetic variants of multiple lncrnas, eg, HOTAIR, H19, PTENP1 and GAS5, were identified to be associated with its carcinogenesis.[@CIT0022]--[@CIT0027]

Recently, LINC00673 rs11655237 was first identified to be associated with susceptibility to pancreatic cancer by a genome-wide association study (GWAS) from North America, Central Europe and Australia.[@CIT0028] Furthermore, another Chinese GWAS by Zheng et al[@CIT0015] replicated the findings in a Chinese population, and found that rs11655237 created a miR-1231 binding site and interferes with PTPN11 degradation. Zhang et al[@CIT0029] verified that the LINC00673 rs11655237 might be associated with neuroblastoma susceptibility. However, the role of functional polymorphisms of lncRNA LINC00673 within the context of GC had not been reported yet. In this study, rs11655237, together with 3 SNPs located in LINC00673 (rs6501551, rs857510, and rs9914618) with RegulomeDB score \<3 were selected as the tagSNPs. We explored their associations with susceptibility of GC, and the possible mechanism.

Methods {#S0002}
=======

Study population {#S0002-S2001}
----------------

We totally included 1392 GC cases and 1,364 healthy controls with the HP infection status in this study. All patients were newly diagnosed incident GC cases and histopathologically confirmed. All participants had no previous history of tumors or history of blood transfusion in the three month prior to surgery resection. The healthy controls were randomly selected during the same time period as the case study from healthy individuals with no history of cancer. Frequency matching of controls to cases was used in the design of this study. Demographic information was obtained from all participants during research interviews using a structured questionnaire. The clinical characteristics of patients were obtained from the electronic medical records. The study was approved by the institutional review board of Liyuan Hospital, and each subject signed an informed consent. The study was conducted in accordance with the Declaration of Helsinki.

SNP selection and genotyping {#S0002-S2002}
----------------------------

SNP rs11655237, together with 3 SNPs located in LINC00673 (rs6501551, rs857510, and rs9914618) with RegulomeDB score \<3 were selected as the tagSNPs using SNPinfo.[@CIT0030],[@CIT0031] The genotypes of SNPs were determined by TaqMan allelic discrimination methods. The random 10% of samples were repeatedly genotyped and the results were 100% concordant.

HP serum detection {#S0002-S2003}
------------------

The HP infection of all participants were detected with a commercial HP testing kit (Shenzhen, China) according to the suggested procedures, which were validated in the Chinese populations with a sensitivity and specificity of more than 99% for the detection of HP infection.

Cell line, construction of reporter plasmids, transient transfections and luciferase assays {#S0002-S2004}
-------------------------------------------------------------------------------------------

The BGC-803 cell line was purchased from the Cell Bank of Type Culture Collection of the Chinese Academy of Sciences Shanghai Institute of Biochemistry and Cell Biology. It was cultured in RPMI 1640 supplemented with 10% fetal bovine serum, at 37 °C in a humid incubator with 5% CO2. The reporter vector was generated encoding the 307-bp LINC00673 exon region flanking rs11655237\[G\] or rs11655237\[A\] using the restriction enzymes XhoI and NotI (Fermentas). Then 800 ng of reporter plasmid was cotransfected into HeLa cells with miR-1231 using Lipofectamine 2000 (Invitrogen). Cells were collected 24 h after transfection, and Renilla luciferase activity was detected and used to normalize firefly luciferase activity.

Quantitative RT-PCR {#S0002-S2005}
-------------------

Total RNAs were isolated using Trizol method and reverse transcribed to cDNA, and subjected for quantitative RT-PCR. The primers of LINC00673 were sense TCCACCCTGGTCTTCTCCTGTAAC and reverse GGTTCAAAGCACCCACCGAGT. The primers for miR-1231 were sense ACAGTCGTGTCTGGGCGGA and the reverse GTGCAGGGTCCGAGGTATTC. The relative normalized quantity of LINC00673 expression was calculated using the 2^−ΔΔCT^ algorithm, with GAPDH employed as an internal control.

Statistical analysis {#S0002-S2006}
--------------------

Demographic characteristics between cases and controls were analyzed using Chi-square test, and differences in continuous variables were tested by Student *t*-test. Hardy-Weinberg equilibrium (HWE) among the controls was tested using a goodness-of-fit χ^2^ test. Unconditional logistic regression model was conducted to calculate odds ratios (ORs) and their 95% confidence internals (CIs) of the association between the SNP and GC risk. All statistical tests were two-sided and conducted using Statistical Program for Social Sciences (SPSS 17.0, Chicago, IL, USA). A two-side *P*-value of \<0.05 was considered as statistically significant.

Results {#S0003}
=======

Population characteristics {#S0003-S2001}
--------------------------

As shown in [Table 1](#T0001){ref-type="table"}, there were no statistically significant differences in age, gender, body mass index (BMI), waist-hip-ratio (WHR). However, compared with the control group, we found the case group have high percentage of HP infection, family history of cancers and drinkers (*P*\<0.001).Table 1Demographic characteristics and HPV infection rates in GC cases and controlsCases (n=1392)Controls (n=1364)*P*-valueAge \<60681 (48.9%)656 (48.1%)0.663 ≥60711 (51.1%)708 (51.9%)Gender Male1013 (72.8%)995 (73.0%)0.918 Female379 (27.2%)369 (27.0%)BMI (kg/m2)24.1±4.724.0±5.30.600WHR0.82±0.310.81±0.340.420Family history of cancer Yes306 (22.0%)112 (8.2%)***P*\<0.001** No1086 (78.0%)1252 (91.8%)Drinking status Yes510 (36.6%)273 (20.0%)***P*\<0.001** No882 (63.4%)1091 (80.0%)HP infection Yes998 (71.7%)750 (55.0%)***P*\<0.001** No394 (28.3%)614 (45.0%)Tumor site cardia533 (38.3%) Non-cardia859 (61.7%)TNM stages I/II722 (51.9%) III/IV670 (48.1%)[^1][^2]

Association studies of LINC00673 gene polymorphisms and GC risk {#S0003-S2002}
---------------------------------------------------------------

As shown in [Table 2](#T0002){ref-type="table"}, the genotype frequencies of the four tagSNPs (rs11655237, rs6501551, rs857510, and rs9914618) among the controls were all in accordance with HWE (*P*\>0.05). We found rs11655237 was significantly associated with susceptibility of GC (OR=1.29; 95% CI=1.12--1.48; *P*=4.1×10^−4^). The AG genotype was associated with a 1.29-fold increased risk (95% CI=1.07--1.54; *P*=0.006) of GC as compared with the GG genotype, while the AA genotype conferred 1.58-fold increased risk of GC compared with the GG genotype (95% CI=1.13--2.22; *P*=0.008). Additionally, we detected an marginal association for rs9914618 (OR=1.21; 95% CI=1.03--1.43; *P*=0.023), although it attenuated for Bonferroni adjustment. Then, we evaluated the interactive effects of HP infection and rs11655237 based on an dominant model. As shown in [Table 3](#T0003){ref-type="table"}, a significant interaction was found between rs11655237 and HP infection (*P*=0.006). Compared with those with AG or AA genotype, carriers of GG genotype are more likely to be infected with HP (OR: 1.24; 95% CI: 1.07--1.44).Table 2Associations between LINC00673 variants and GC susceptibilitySNPComparisonCases (n=1392)Controls (n=1364)OR (95% CI) ^a^*P*-valuers11655237GG7758381.00 (Reference)AG5224581.29 (1.07--1.54)**0.006**AA95681.58 (1.13--2.22)**0.008**A vs G1.29 (1.12--1.48)**4.1×10^−4^**rs6501551AA103510231.00 (Reference)AG3193061.07 (0.72--1.59)0.731GG38351.15 (0.61--2.13)0.756G vs A1.08 (0.81--1.45)0.649rs857510GG9429221.00 (Reference)AG4154041.05 (0.29--3.81)0.946AA35380.96 (0.78--1.19)0.738A vs G1.03 (0.61--1.74)0.906rs9914618GG9289601.00 (Reference)AG4143631.23 (1.01--1.49)**0.042**AA51411.34 (0.84--2.13)0.217A vs G1.21 (1.03--1.43)**0.023**[^3][^4] Table 3Results for gene-environment interaction analysis for rs11655237 and HP infectionSNPHP infectionNoYesCaseControlOR(95% CI)^a^CaseControlOR(95% CI)^a^**rs11655237**GG2013551.00 (reference)5744831.00 (reference)AG + AA1932591.32 (1.02--1.7)4242671.34 (1.1--1.62)aa*P*-interaction=0.006[^5][^6]

Relative expression of LINC00673 in gastric tissues {#S0003-S2003}
---------------------------------------------------

Then, we examined expression level of LINC00673 and the potential effect of rs11655237 in 94 randomized selected GC tissues and adjacent normal tissues ([Figure 1](#F0001){ref-type="fig"}). Among all the pairs of GC patients, the expression levels of lncRNA LINC00673 in GC tissues were significantly lower than those in the corresponding normal tissues (*P*\<0.001). And the results showed that individuals with the GG genotype of rs11655237 had significantly higher LINC00673 levels than those with the GA or AA genotype (*P*\<0.001). However, the expression level of miR-1231 showed no difference in the GC tissues ([Figure 2](#F0002){ref-type="fig"}, *P*=0.793).Figure 1Relative expression of LINC00673 in GC tissues and adjacent normal tissues.Figure 2Levels of miR-1231 determined by quantitative RT--PCR in GC tissues.

Mechanism exploration of rs11655237 affecting function of LINC00673 {#S0003-S2004}
-------------------------------------------------------------------

We investigated whether interaction between miR-1231 and LINC00673 existed in a LINC00673 variant-specific manner in BGC-803 cells. As shown in [Figure 3](#F0003){ref-type="fig"}, luciferase reporter assays showed that, in comparison to the construct with the rs11655237\[G\] allele, the construct with the rs11655237\[A\] allele had significantly reduced luciferase activity in the presence of miR-1231, and this effect could be completely rescued when miR-1231 inhibitor was present. We also found no difference for the expression of miR-1231 in BGC-803 cell line with different alleles of rs11655237 ([Figure 4](#F0004){ref-type="fig"}, *P*=0.821). These indicated that LINC00673 rs11655237 \[A\] is a target of miR-1231.Figure 3Relative reporter gene activity of the rs11655237 in BGC-803 cell line. Figure 4Levels of miR-1231 determined by quantitative RT--PCR in BGC-803 cell line.

Discussion {#S0004}
==========

To the best of our knowledge, this should be the first study aiming to evaluate the function of variants of lncRNA LINC00673 on the GC carcinogenesis. We found that rs11655237 was significantly associated with GC susceptibility; and a significant interaction between rs11655237 and HP infection was detected for GC risk. RT-PCR showed that LncRNA LINC00673 was down-regulated in GC tissues, and allele A of rs11655237 could significantly decrease the expression level of LINC00673. This was possibly caused by down-regulating LINC00673 expression through creating a miR-1231 binding site. These results highlight an important functional interaction between lncRNAs and miRNAs in the process of GC carcinogenesis.

In recent years, the roles of LncRNAs in human disease, including cancer, have attracted much attention.[@CIT0021],[@CIT0032]--[@CIT0035] First, LINC00673 was identified as new locus for susceptibility to pancreatic cancer in the European population in 2015.[@CIT0028] Then, Zheng et al[@CIT0015] identified LINC00673 for its role in maintaining cell homeostasis and its germline variation might confer susceptibility to pancreatic cancer. Huang et al[@CIT0013] identified that SP1-activated LINC00673 exerts an oncogenic function that promotes gastric cancer development and progression, by functioning as a scaffold for LSD1 and EZH2 and repressing KLF2 and LATS2 expression; Lu et al[@CIT0012] found that LINC00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p, and LINC00673 expression was associated with poor prognosis of NSCLC patients. Yu et al[@CIT0014] also showed that LINC00673 was associated with poor prognosis and promoted invasion and metastasis in tongue squamous cell carcinoma. Taking together, all studies above indicated the essential role of LINC00673 in the carcinogenesis and tumor progression.

In current study, we found LINC00673 rs11655237 is associated with an increased GC risk, which was consistent with the findings in other cancers.[@CIT0015],[@CIT0028],[@CIT0029] Besides, we also detected a significant interaction between rs11655237 and HP infection. Compared with those with AG or AA genotype, carriers of GG genotype are more likely to be infected with HP. HP infection is an important risk factor for gastric cancer. Previous studies have identified HP infection could interacted with genetic polymorphisms in carcinogenesis process, through inflammatory signaling, inflammasome formation and autophagy.[@CIT0036]--[@CIT0038] Further, to elucidate biological function of lncRNA LINC00673 and its variant- rs11655237 on GC carcinogenesis, we investigated the association of the rs11655237 genotype with LINC00673 expression in GC and adjacent normal tissues. We found the expression levels of lncRNA LINC00673 in GC tissues were significantly lower than those in the corresponding normal tissues, and allele A of rs11655237 could significantly decrease the expression level of LINC00673. These results indicate that LINC00673 might be a tumor suppressor in GC while rs11655237 A allele suppresses the transcription of lncRNA LINC00673. The G\>A mutation at rs11655237 was predicted to change the local folding structures and free energy of lncRNA LINC00673.[@CIT0015],[@CIT0039] Additionally, LINC00673 rs11655237\[A\] has been identified as a target of miR-1231 in in both BXPC-3 and CFPAC-1 cells.[@CIT0015] In this study, we also tested whether interaction between miR-1231 and LINC00673 existed in a LINC00673 variant-specific manner in BGC-803 cells, and we confirmed that LINC00673 rs11655237 \[A\] was also a target of miR-1231 in GC cell line. Taking together, these results indicate that miR-1231 is an inhibitor of LINC00673\[A\] but not LINC00673\[G\].

Conclusively, the present study investigated the association of LINC00673 rs11655237 with GC risk, and its interaction with HP infection. We identified LINC00673 rs11655237 significantly increased susceptibility of GC in the Chinese population, possibly by down-regulating LINC00673 expression through creating a miR-1231 binding site. Follow-up studies, including functional studies, are needed to fully understand the importance of LINC00673 and its variants in GC risk.

Abbreviation list {#S0005}
=================

CIs, confidence intervals; ORs, odds ratios; GWASs, genome-wide association studies; SNP, single nucleotide polymorphism.
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[^1]: **Note:** Bold values indicate statistically significant.

[^2]: **Abbreviations:**BMI, body mass index; GC, gesteric cancer; HP, *Helicobacter pylori*; WHR, waist-hip-ratio.

[^3]: **Notes:** ^a^Adjusted for age, gender, BMI, WHR, family history of cancer, drinking status, and HP infection. Bold values indicate statistically significant.

[^4]: **Abbreviations:** BMI, body mass index; GC, gastric cancer; HP, *Helicobacter pylori*; WHR, waist-hip-ratio.

[^5]: **Notes:** ^a^Adjusted for age, gender, BMI, WHR, family history of cancer, and drinking status.

[^6]: **Abbreviations:** BMI, body mass index; HP, *Helicobacter pylori*; WHR, waist-hip-ratio.
